-
GMDAQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Gamida Cell (GMDAQ)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.78 mm | 24.78 mm | 24.78 mm | 24.78 mm | 24.78 mm | 24.78 mm |
Cash burn (monthly) | 7.26 mm | 1.83 mm | 8.38 mm | 6.55 mm | 7.67 mm | 6.65 mm |
Cash used (since last report) | 63.77 mm | 16.09 mm | 73.60 mm | 57.53 mm | 67.34 mm | 58.44 mm |
Cash remaining | -38.99 mm | 8.68 mm | -48.82 mm | -32.76 mm | -42.56 mm | -33.66 mm |
Runway (months of cash) | -5.4 | 4.7 | -5.8 | -5.0 | -5.6 | -5.1 |
13F holders | Current |
---|---|
Total holders | 60 |
Opened positions | 14 |
Closed positions | 21 |
Increased positions | 11 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 27.46 bn |
Total shares | 50.17 mm |
Total puts | 34.80 k |
Total calls | 79.40 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
AI Gamida | 9.74 mm | $19.19 mm |
FMR | 6.92 mm | $8.93 bn |
Community US Fund Management | 5.04 mm | $8.16 mm |
Novartis Pharma | 4.34 mm | $5.59 mm |
Highbridge Capital Management | 4.22 mm | $0.00 |
Rock Springs Capital Management | 4.12 mm | $5.31 bn |
Meitav Dash Investments | 3.66 mm | $4.63 bn |
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet | 2.21 mm | $2.80 bn |
Israel HealthCare Ventures 2 | 1.89 mm | $15.86 mm |
EMITF Elbit Imaging | 1.83 mm | $15.34 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | Joshua F. Patterson | Ordinary Shares | Grant | Acquire A | No | No | 0 | 480,319 | 0.00 | 855,461 |
31 Jan 24 | Julian Adams | Ordinary Shares | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 423,750 |
31 Jan 24 | Tomasello Shawn | Ordinary Shares | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 241,977 |
31 Jan 24 | Korfin Michele Ilene | Ordinary Shares | Grant | Acquire A | No | No | 0 | 480,319 | 0.00 | 702,981 |
31 Jan 24 | Moch Kenneth I | Ordinary Shares | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 232,300 |